Document is current

Article History

Received: 13 July 2021

Accepted: 20 January 2022

First Online: 15 February 2022

Declarations

:

: The project (incl. protocol) was approved by the local ethics committees of the University Hospital Munich and the University of Ulm in accordance with the Declaration of Helsinki. Study participants were informed about the study via an information sheet and were asked to provide written informed consent to participate. Furthermore, all methods were carried out in accordance with the Declaration of Helsinki. All participants received a written declaration of consent prior to participation in the study, which also included consent to the publication of anonymous data of individual participants.

: Not applicable.

: Gabriele Gaigl, Esther Täumer, Andreas Allgöwer, Thomas Becker, Johanna Breilmann, Peter Falkai, Uta Gühne, Reinhold Kilian, Steffi G. Riedel-Heller, Klemens Ajayi, Jessica Baumgärtner, Peter Brieger, Karel Frasch, Stephan Heres, Markus Jäger, Andreas Küthmann, Albert Putzhammer, Bertram Schneeweiß, Michael Schwarz and Markus Kösters report no conflicts of interest. Alkomiet Hasan has been invited to scientific meetings by Lundbeck, Janssen, and Pfizer, and he received paid speakerships from Desitin, Janssen, Otsuka, and Lundbeck. He was member of Roche, Otsuka, Lundbeck, and Janssen advisory boards.